Posting just to write down my thoughts.
Whilst it varies, I have FID FUMAA ending at about 11.5bn (fairly sizeable drawdown in FUM in June).
Average FUM throughout the year (June '21 + June '22)/2 = ~11bn
At an estimated $6.8m/$1bn of FUMAA, I get ~75m in revenue.
Net Income (after fees and charges) of 74% = $55.5m
CTI on that of 53% = $29.41m
D&A excl customer amortization is basically 0.
That should leave ~$29m in PBT.
Tax rate of 27.5% = $21m PAT
Current MC = $230m
Cash ~$17m at EOY (guessing, depends on timing of payments, etc)
EV = $213m
Basically trading on 10x EV/FCF from what I can tell. Plenty of room for growth from:
- acquisition of more FUA, then transfering across to management/platform
- recovery across equity/bond markets
- Onboarding external funds onto the platform
Potential loss of earnings from reduction in platform pricing... Unsure how to factor this in as I don't know the pricing structure.
- Forums
- ASX - By Stock
- FID
- Ann: FID Investor Presentation - Wilsons
FID
fiducian group limited
Add to My Watchlist
2.26%
!
$9.50

Ann: FID Investor Presentation - Wilsons, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.50 |
Change
-0.220(2.26%) |
Mkt cap ! $299.8M |
Open | High | Low | Value | Volume |
$9.73 | $9.74 | $9.50 | $19.82K | 2.055K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 526 | $9.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.79 | 452 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 526 | 9.500 |
1 | 250 | 9.480 |
1 | 2000 | 9.220 |
1 | 2000 | 9.210 |
1 | 2100 | 9.180 |
Price($) | Vol. | No. |
---|---|---|
9.790 | 452 | 1 |
9.840 | 197 | 1 |
9.850 | 3000 | 1 |
9.870 | 616 | 1 |
9.900 | 133 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
FID (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online